Evidence map›Paper›PMID 31496162›Full record

ArticleZhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences2019

[High dose vitamin C inhibits proliferation of breast cancer cells through reducing glycolysis and protein synthesis].

Qingmei Wang, Qianzi Xu, Anyi Wei, Shishuo Chen, Chong Zhang, Linghui Zeng

Open access · greenAbstract read
In one paragraph

Article in Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Qingmei WangSchool of Medicine, Zhejiang University City College, Hangzhou 310015, China.
Qianzi XuSchool of Medicine, Zhejiang University City College, Hangzhou 310015, China.
Anyi WeiSchool of Medicine, Zhejiang University City College, Hangzhou 310015, China.
Shishuo ChenSchool of Medicine, Zhejiang University City College, Hangzhou 310015, China.
Chong ZhangSchool of Medicine, Zhejiang University City College, Hangzhou 310015, China.
Linghui ZengSchool of Medicine, Zhejiang University City College, Hangzhou 310015, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the effects of high dose vitamin C (VC) on proliferation of breast cancer cells and to explore its mechanisms.

methodsHuman breast cancer cells Bcap37 and MDA-MB-453 were treated with VC at low dose (0.01 mmol/L), medium dose (0.10 mmol/L) and high dose (2.00 mmol/L). Cell proliferation was determined with CCK-8 assay, protein expression was evaluated by Western blot, and the secretion of lactic acid in tumor cells was detected by colorimetric method. Bcap37 cells were inoculated in nude mice, and tumor baring nude mice were intraperitoneally injected with high VC(4 g/kg, VC group,

results

conclusionsHigh dose VC may inhibit proliferation of breast cancer cells both

Indexed as

Ascorbic AcidBreast NeoplasmsGlycolysisProtein BiosynthesisAnimalsCell Line, TumorCell ProliferationHumansMiceMice, NudeProhibitinsAscorbic AcidPHB2 protein, humanPhb2 protein, mouseProhibitins

Identifiers

PMID31496162
PMCPMC8800810
OpenAlexW2973360008

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.